VKTX

VIKING THERAPEUTICS INC

VKTX·92686J106·US·Common Stock·Healthcare - Biotechnology-13D/G

VKTX (VIKING THERAPEUTICS INC) is held by 167 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($223.9M), FMR LLC ($196M), VANGUARD CAPITAL MANAGEMENT LLC ($163.1M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 93 funds bought VKTX.

167
Holders
Avg rating(31 Elite)
$2.1B
Total Value
53% (184)
Fund Consensus
93 buying - 81 selling
VKTXSmart Money Verdict
View all
Held by 167 funds
31 elite
Who's Trading
ActivistVAVanguard Capital Management5.1%Apr 30, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderAWAubuchon Neil WilliamBuy $150KMar 10, 2026
ActivistFMR LLCFMR LLC5.1%Nov 5, 2025
InsiderLBLian BrianSell $1.4MOct 28, 2025
InsiderMMMancini MariannaSell $216KOct 28, 2025
InsiderZGZANTE GREGSell $216KOct 28, 2025
InsiderRJRowland Charles A JrSell $2.1MOct 27, 2025
InsiderLBLian BrianSell $748KJul 3, 2025
CongressDonald J. TrumpDonald J. TrumpBuy $15,001 - $50,000Apr 8, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.9M(+4.1%)$223.9M0.0%+1.48%
32
Decreased
6M(-8.1%)$196M0.0%-0.99%
0
New
5M$163.1M0.0%+21.70%
42
New
4.5M$145.3M0.0%+21.70%
42
Increased
4.4M(+82.0%)$144.2M0.1%+31.65%
56
Decreased
4.4M(-1.1%)$143M0.0%+28.40%
0
Increased
2.1M(+125.1%)$113.5M0.0%+16.75%
48
Decreased
3M(-2.0%)$98.1M0.0%-12.32%
0
Increased
2.1M(+4.4%)$67.8M0.0%+69.74%
31
Increased
2.1M(+580.7%)$67.6M0.0%+30.61%
48
Increased
1.7M(+25.4%)$54.6M0.0%-0.84%
36
Decreased
1.7M(-2.4%)$54.6M0.0%+10.90%
0
Increased
1.3M(+44.1%)$43.8M0.0%+30.49%
39
Decreased
1.3M(-27.1%)$41.1M0.0%-8.64%
0
Increased
960,570(+15.4%)$31.3M0.0%+15.31%
33
Decreased
748,949(-50.1%)$24.4M0.0%+28.49%
0
Increased
736,465(+5.2%)$24M0.0%+81.42%
30
New
710,412$23.1M0.0%+21.70%
40
Decreased
705,809(-50.4%)$23M0.0%+0.94%
0
Decreased
696,301(-7.5%)$22.7M0.0%-5.95%
0

Showing 1-20 of 184

1 / 10

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used